NCT06557460 A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) Status RECRUITING Phase PHASE2
NCT06536062 Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma. Status RECRUITING Phase NA
NCT06351605 A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT) Status RECRUITING Phase N/A
NCT06229665 Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06165068 Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study Status RECRUITING Phase PHASE3
NCT05797896 Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05706896 Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma Status RECRUITING Phase NA
NCT05667688 Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85 Status COMPLETED Phase PHASE1
NCT05447650 Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) Status COMPLETED Phase NA
NCT05418231 Observation of the Natural Course of Age-related Macular Degeneration Status NOT_YET_RECRUITING Phase N/A
NCT04875234 Vision Improvement for Legally Blind Dry AMD Patients Status NOT_YET_RECRUITING Phase N/A
NCT04643886 A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration Status TERMINATED Phase PHASE2
NCT04636853 CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration Status COMPLETED Phase PHASE3
NCT04627428 Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) Status RECRUITING Phase PHASE1/PHASE2
NCT04566445 HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Status TERMINATED Phase PHASE2
NCT04511936 Microcurrent Stimulation for Dry Age-related Macular Degeneration Status WITHDRAWN Phase NA
NCT04437368 EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Status TERMINATED Phase PHASE2
NCT04358471 Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA) Status WITHDRAWN Phase PHASE2
NCT04349254 Observational Study of Vision Improvement in Late Stage Dry AMD Patients Status COMPLETED Phase N/A